Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-Modulated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02606708
What this trial is testing

Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy

Who this might be right for
Breast Cancer
NYU Langone Health 314
Large-scale testing (Phase 3)Study completedNCT00158678
What this trial is testing

IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC

Who this might be right for
Oral CancerOropharynx CancerHypopharynx Cancer
Groupe Oncologie Radiotherapie Tete et Cou 310
Testing effectiveness (Phase 2)Ended earlyNCT01843452
What this trial is testing

Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

Who this might be right for
Carcinoma of Anal Canal
Centre Hospitalier Universitaire Vaudois 8
Testing effectiveness (Phase 2)UnknownNCT01697891
What this trial is testing

A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers

Who this might be right for
Head and Neck CancerDysphagia
McMaster University 35
Testing effectiveness (Phase 2)Study completedNCT01230996
What this trial is testing

Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Barts & The London NHS Trust 22
Not applicableUnknownNCT03554135
What this trial is testing

Single frActIoN eighT Gray Palliative Radiotherapy With Modulated Intensity for Pain Reduction

Who this might be right for
Bone MetastasesRadiotherapyTechnology
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)UnknownNCT00667888
What this trial is testing

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 225
Testing effectiveness (Phase 2)Study completedNCT00833261
What this trial is testing

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)UnknownNCT05114707
What this trial is testing

Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Who this might be right for
Nasal Cavity CancerParanasal Sinus CancerCamrelizumab+3 more
Sun Yat-sen University 57
Not applicableUnknownNCT05859828
What this trial is testing

The GOAL27-6 Study

Who this might be right for
Head and Neck Cancer
East and North Hertfordshire NHS Trust 60
Not applicableLooking for participantsNCT05761054
What this trial is testing

Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)

Who this might be right for
Soft Tissue Sarcoma
Azienda Ospedaliero-Universitaria Careggi 33
Not applicableUnknownNCT03535207
What this trial is testing

High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Testing effectiveness (Phase 2)Looking for participantsNCT05388773
What this trial is testing

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
Heath Skinner 150
Not applicableUnknownNCT00407875
What this trial is testing

Intensity Modulated Versus Interstitial - Radiation Therapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 50
Large-scale testing (Phase 3)WithdrawnNCT00258466
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT02993653
What this trial is testing

Intensity-modulated Radiotherapy Protocol in Cervix Cancer

Who this might be right for
Radiation
Seoul St. Mary's Hospital 80
Not applicableStudy completedNCT03471741
What this trial is testing

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Who this might be right for
Breast CancerRadiation Toxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Not applicableStudy completedNCT04323722
What this trial is testing

Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 53
Early research (Phase 1)Ended earlyNCT01324141
What this trial is testing

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

Who this might be right for
Anal Cancer
National Cancer Institute (NCI) 6
Next Page